Delivery Order SPE2DB22D2206-SPE2DB24FJG05

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order, valued at $1,848.86, is for the supply of Oxycontin ER 20 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of OxyContin ER 20 mg tablets. The contract is a Delivery Order valued at $1,941.97 with a firm fixed price and a completion date of March 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award, valued at $1,298.68, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of Oxycontin ER 10 mg tablets in quantities of 100s. This award does not have a set-aside designation and is a firm-fixed-price delivery order contract with a completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor in the United States, has been...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,331.70, is a delivery order to provide OxyContin ER 20 mg tablets in 100 counts. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $3,557.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award provides for the delivery of 4,554,721,502 units of Oxycontin ER 30 mg tablets. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999 through November 2026. The IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,543.23 firm-fixed-price delivery order is for the supply of 4,566,674,910 OxyContin ER 20 mg tablets, with a performance period running through December 11, 2024. This order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,127.30 firm-fixed-price delivery order contract is for the supply of Oxycontin ER 20 mg tablets in 100-count bottles. The contract has a completion date of February 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award of $2,122.91 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxycontin ER 20 mg tablets, a pharmaceutical product, and has an ultimate completion date of May 3, 2024. The contract is a firm fixed-price Delivery Order, with no set-aside designation. Amerisourcebergen is the prime contractor, and the contract is part of a larger...
This federal contract award, valued at $1,096.81, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of OxyContin ER 20 mg tablets in quantities of 100. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for a broad range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,850,528 Oxycontin ER 10 mg tablets in 100-count bottles. The $1,377.50 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) on June 7, 2024, with a completion date of June 10, 2024. This award does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC) valued...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJG05
    Delivery Order

This federal contract award, valued at $1,660.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oxycontin ER 20 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of July 18, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for supplying a wide range of pharmaceutical and medical products to support federal healthcare programs and facilities. This contract award does not have a set-aside designation.

Generated 10/16/24, 9:03 AM